Hirsutism causes: Difference between revisions
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 21: | Line 21: | ||
{| style="width:80%; height:100px" border="1" | {| style="width:80%; height:100px" border="1" | ||
| style="width:25%" bgcolor="LightSteelBlue" ; border="1" |'''Cardiovascular''' | | style="width:25%" bgcolor="LightSteelBlue" ; border="1" |'''Cardiovascular''' | ||
| style="width:75%" bgcolor="Beige" ; border="1" | | | style="width:75%" bgcolor="Beige" ; border="1" | [[Insulin resistance syndrome]] | ||
|- | |- | ||
| bgcolor="LightSteelBlue" | '''Chemical/Poisoning''' | | bgcolor="LightSteelBlue" | '''Chemical/Poisoning''' | ||
Line 32: | Line 32: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" | [[Dermatomyositis]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" |[[Aripiprazole]], [[bimatoprost]], [[bupropion]], [[carbamazepine]], [[clonazepam]], [[corticosteroids]], [[cyclosporine]], [[danazol]], [[dantrolene]], [[desogestrel and ethinyl estradiol]], [[dexamethasone]], [[diazoxide]], [[donepezil]], [[estrogens]], [[eszopiclone]], [[ethosuximide]], [[ethotoin]], [[ethynodiol diacetate and ethinyl estradiol]], [[fluoxetine]], [[fluoxymesterone]], [[gestrinone]], [[pegylated interferon alfa-2a|interferon alfa]], [[isotretinoin]], [[lamotrigine]], [[leuprolide]], [[methyltestosterone]], [[mycophenolate]], [[olanzapine]], [[oxandrolone]], [[oxymetholone]], [[paroxetine]], [[phenytoin]], [[prednisolone]], [[pregabalin]], [[progestin]], [[selegiline]], [[tacrolimus]], [[testosterone]], [[tiagabine]], [[trazodone]], [[valproic acid]], [[vasodilators]], [[venlafaxine]], [[zonisamide]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
Line 58: | Line 44: | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
| bgcolor="Beige" | | | bgcolor="Beige" |[[Acromegaly]], [[adrenal adenoma]], [[adrenal carcinoma]], [[adrenal tumor]], [[arrhenoblastoma]], [[congenital adrenal hyperplasia]], [[Cushing syndrome]], [[Cushing's disease]], [[hyperprolactinemia]], [[hypothyroidism]], [[insulin resistance syndrome]], [[luteoma]], [[pituitary tumor]], [[polycystic ovary syndrome]], [[porphyria cutanea tarda]], [[Stein-Leventhal syndrome]], [[testosterone]] | ||
|- | |- | ||
|- bgcolor="LightSteelBlue" | |- bgcolor="LightSteelBlue" |
Revision as of 15:43, 22 September 2017
Hirsutism Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Hirsutism causes On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: ; Ogheneochuko Ajari, MB.BS, MS [2] Rasam Hajiannasab M.D.[3]
Overview
The cause of hirsutism can be either an increased level of androgens (male hormones) or an oversensitivity of hair follicles to androgens, and the most common cause is polycystic ovary syndrome. Male hormones such as testosterone stimulate hair growth, increase size and intensify the pigmentation of hair. Other symptoms associated with a high level of male hormones include acne and deepening of the voice and increased muscle mass. Growing evidence implicates high circulating levels of insulin in women to the development of hirsutism. This theory is consistent with the observation that obese (and thus presumably insulin resistant hyperinsulinemic) women are at high risk of becoming hirsute. Further, treatments that lower insulin levels will lead to a reduction in hirsutism.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. There are no known life threatening causes of hirsutism.
Common Causes
- Androgen secreting tumors
- Congenital adrenal hyperplasia
- Cushing's syndrome
- Idiopathic hirsutism
- Polycystic ovary syndrome [1]
Causes by Organ System
Cardiovascular | Insulin resistance syndrome |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | Dermatomyositis |
Drug Side Effect | Aripiprazole, bimatoprost, bupropion, carbamazepine, clonazepam, corticosteroids, cyclosporine, danazol, dantrolene, desogestrel and ethinyl estradiol, dexamethasone, diazoxide, donepezil, estrogens, eszopiclone, ethosuximide, ethotoin, ethynodiol diacetate and ethinyl estradiol, fluoxetine, fluoxymesterone, gestrinone, interferon alfa, isotretinoin, lamotrigine, leuprolide, methyltestosterone, mycophenolate, olanzapine, oxandrolone, oxymetholone, paroxetine, phenytoin, prednisolone, pregabalin, progestin, selegiline, tacrolimus, testosterone, tiagabine, trazodone, valproic acid, vasodilators, venlafaxine, zonisamide |
Ear Nose Throat | No underlying causes |
Endocrine | Acromegaly, adrenal adenoma, adrenal carcinoma, adrenal tumor, arrhenoblastoma, congenital adrenal hyperplasia, Cushing syndrome, Cushing's disease, hyperprolactinemia, hypothyroidism, insulin resistance syndrome, luteoma, pituitary tumor, polycystic ovary syndrome, porphyria cutanea tarda, Stein-Leventhal syndrome, testosterone |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic |
|
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | |
Oncologic | No underlying causes |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | No underlying causes |
Rheumatology/Immunology/Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Causes in Alphabetical Order
References
- ↑ Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR (2004). "Androgen excess in women: experience with over 1000 consecutive patients". J. Clin. Endocrinol. Metab. 89 (2): 453–62. doi:10.1210/jc.2003-031122. PMID 14764747.